Table 2_Harnessing mRNA technology against Fasciola hepatica: Immunological insights from a fatty acid binding protein vaccine.docx

<p>mRNA platforms offer a promising strategy to overcome limitations in helminth vaccinology. We used the helminth Fasciola hepatica, which is a major veterinary and zoonotic pathogen for which no licensed vaccine exists, as a test case. We engineered a codon-optimized mRNA encoding the F. hep...

Повний опис

Збережено в:

Бібліографічні деталі
Автор:	Javier Sánchez-Montejo (22681769) (author)
Інші автори:	Cristina Teodosio (143750) (author), Tania Strilets (14883102) (author), Julio López-Abán (134057) (author), Raúl Manzano-Román (3335778) (author), Julio Pozo (18986489) (author), Silvia Martin (22681772) (author), Lidia Silos (20912975) (author), Ignacio Trujillo (16072388) (author), Mariano A. García-Blanco (22681775) (author), Belén Vicente (615664) (author), Antonio Muro (134062) (author)
Опубліковано:	2025
Предмети:	Genetic Immunology Fasciola hepatica parasite trematode mRNA vaccine cytometry FABP
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!

Table 2_Harnessing mRNA technology against Fasciola hepatica: Immunological insights from a fatty acid binding protein vaccine.docx

Схожі ресурси